2 Hot Stocks to Watch: Baozun Inc. (NASDAQ:BZUN), TG Therapeutics, Inc. (NASDAQ:TGTX)

Baozun Inc. (NASDAQ:BZUN)

The shares of Baozun Inc. (NASDAQ:BZUN) started off the last trading session with the price of $48.5 while closing the day with the price of $47.88. The shares of Baozun Inc. (NASDAQ:BZUN) Rise 0.21% with the Loss of -0.62 points.

The shares of Baozun Inc. (NASDAQ:BZUN) traded with the day volume of 2.74 Million shares whereas its average trading volume is 2.12 Million.

While analyzing the past performance of the stock we can see that the shares of Baozun Inc. (NASDAQ:BZUN) Gain 34.19% in the last week while rising 41.82% in the last month. Past quarter performance shows the green light with 69.37%. The semi-annual and annual performance shows 53.86% and 209.5% respectively.

Some critical values of the shares of Baozun Inc. (NASDAQ:BZUN) to be discussed here are: the beta which shows the value at 0 while Average True Range of Baozun Inc. (NASDAQ:BZUN) demonstrate the value at 2.85. The weekly and monthly volatility of the shares of Baozun Inc. (NASDAQ:BZUN) are indicated at 8.64% and 6.16%. Also to discuss here is the Relative Strength Index or RSI which is depicted at 69.26.

While studying the financial position of the shares of Baozun Inc. (NASDAQ:BZUN), we can see that the Market capitalization of the company is at 2.61 Billion. The shares outstanding for the company is 54.56 Million and the shares float stands at 2.97 Million. The income of the company stand at 32.9 Million while the sales stand at 654.5 Million.

Here are some critical ratios for a financial perspective: Earnings Per Share or EPS of the company stand at 0.56, Price to Earnings or P/E is at 85.65, Price to Sales P/S show the value of 3.99, the Return on Asset ROA stood at 0.083 and the Return on Equity ROE depicted at 0.125 while Return on Investment ROI is at 0.097.


TG Therapeutics, Inc. (NASDAQ:TGTX)

TG Therapeutics, Inc. (NASDAQ:TGTX) started its previous trading session at $17.1 and closed at $16.55 showing a Rise of 0.61 Percent.

The Company traded with an average Volume of 1.59 Million whereas, its Day Volume stood at 2.74 Million.

Looking at the performance of the stock, TG Therapeutics, Inc. (NASDAQ:TGTX) Gain 10.52% in the last week in its shares price and 33.47% in the last month. Quarterly performance shows a green of 109.49 Percent while Semi-Annual and Annual performances shows a 30.83 and 40.25 percent respectively.

Beta for TG Therapeutics, Inc. (NASDAQ:TGTX) stands at 1.2 while the ATR (average true range) is at 0.97. The Stock’s Weekly and Monthly Volatility is 7.52% and 7.05% respectively showing a RSI value of 79.23.

While studying the financial position of the shares of TG Therapeutics, Inc. (NASDAQ:TGTX), we can see that the Market capitalization of the company is at 1.16 Billion. The shares outstanding for the company is 70.22 Million and the shares float stands at 56.54 Million.

The Company generated an income of -111300000 and the sales of 200000 in the Trailing Twelve Months period.

While analyzing the stock from technical aspects, Diluted Earnings per share stands at $-1.94 a share. P/E (price to earnings) and P/S (price to sales) values are 0 and 5810.7 respectively.

The Return on Assets stands at -1.098, ROE shows a value of -1.421 and ROI for TG Therapeutics, Inc. (NASDAQ:TGTX) is 0 as of Trailing Twelve Months period.

View all contributions by

Eldred Matthew covers Healthcare Sector Company recent Press Releases news updates. He has three year of experience in content writing as freelance writer. He performs analysis of Healthcare Companies and provides worthy information for investor community. He is an experienced writer with a precise grasp of the English language and a clear, compelling writing style.

    Leave a Comment